Physician profile
Jonathan Limberakis
NPI 1780098210
$1,071.91
in general payments reported to CMS, 2019-2025
7 companies · $371 in 2025
The $371 reported for 2025 was more than what 87% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $125 · 2021: $25.92 · 2022: $51.42 · 2023: $91.50 · 2024: $191 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $500 · Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $500.00 |
| Food and Beverage | $154.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $464.81 | 2022-2025 | Invisalign, Invisalign Go, Itero Element 5d Plus Lite |
| Janssen Pharmaceuticals, INC | $202.53 | 2019 | |
| Dentsply Sirona INC | $184.66 | 2019-2024 | Consumable Dentistry, Astra Tech Implant System |
| Straumann USA LLC | $150.00 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $32.33 | 2021-2025 | Arestin |
| Zimmer Biomet Holdings, INC. | $25.05 | 2020 | |
| Ortho Organizers, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Limberakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.